<

 
Data updated 2024-11-15 00:05:01
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date10798728.1 (espacenet)  (Federated)  (European Patent Register), 20101210
Patent/reg. no. and dateDK/EP 2513146, 20170503
Publication date20121024
Priority no. and dateGB 0922143, 20091218, GB 201009307, 20100603, GB 1009307, 20100603
EP pub. no. and date EP 2513146 20121024
Effective date
Applicant/ownerKancera AB, Karolinska Science Park
Banvaktsvägen 22
171 48 Solna, SE
Applicant ref. no.P41204548EP00
InventorMELLSTEDT, HÃ¥kan, Nybrogatan 45 B
Stockholm 114 39, SE,
RABBANI, Hodjattallah, Midskeppsgatan 1
5 tr
120 79 Stockholm, SE,
TEIGE, Ingrid, Raketgatan 6
244 57 Lund, SE
RepresentativeNovitas Patent AB, P.O. Box 55557 102 04 Stockholm, SE
Opponent
IPC ClassC07K 16/28 (2006.01) 
TitleANTISTOFFER MOD ROR1, DER ER I STAND TIL AT FREMKALDE CELLEDØD AF CLL
Int. application no.EP2010007524
Int. publication no.WO2011079902
Related patent (certificate)
StatusOphævet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact